Medpace Holdings (MEDP) stock

Market cap $17B

$599.47

+0.23%

Market closed. Prices as of today's close.

Quality Score

Average

In its industry

#37of 300

Biotech

Checks firing

3of 14

Trending up

From 52-week high

-11.6%

Above the 200-day

Pro members see every stock ranked and every check behind each score, live.

See all 14 checks on MEDPFree for 24 hours. No account needed.

Quality Score

Why MEDP scores 9

AverageTrending up, 3 of 14 checks firingWhat the Quality Score means

Poor is below 0. Average starts at 6, Above Average at 11, Excellent at 15, and Exceptional at 20.

+3Chart checks 3 of 14 firing right now, one point each
+3Long-term trend above a rising 200-⁠day average, at a multi-⁠year high

Size adds
Profit addsRead on the last four quarters against the four before, or the last full year where no quarters are filed.
Growth addsSales and margins against a year earlier: up to +3 for fast growth and widening margins, down to -2 when both shrink.
Persistence adds
Insider trades subtracts

No effect today: Run-up, Dilution, Volatility, Cash flow, and News.

What every line is worth, and the reason behind it, on MEDP and every other stock.Get in free →

Price, score, chart checks, and the industry rank are from a snapshot taken at 8:46 PM ET, at least 15 minutes behind. How we rank stocks.

What's next

Reports Wed Oct 21, after the close

After its last 4 reports it closed -3.7% on average, higher 2 of 4 times.

Thu Oct 22: Q3 2026 Earnings Conference CallDate confirmed.

What would move MEDP's score: 6 things, for Pro members

Alert me when MEDP's Quality Score turns up

Free for 24 hours. No account needed. Then keep going with a free account.

Pro

Here is what Pro members see.

Every stock has a live page like this, MEDP included: the price in real time, the full chart, all 14 checks, and every line of its score.

AMD's page for Pro members on a phone, recorded live: the price changes as it trades, beside its Quality Score and its rank, with the bid and ask under it and a year of candles below — The same page for Pro members, on AMDThe live price and the full chart, with the Quality Score drawn under it and the line that drives it.

A Pro member's stock page for AMD: its Quality Score with its rank and the line driving it, the live price with the bid and ask, the chart checks, strength, and next earnings, and a year of candles with the 21 and 50-day averages and the Quality Score drawn under the chart — The same page for Pro members, on AMDThe live price and the full chart, with the Quality Score drawn under it and the line that drives it.

The Score tab on a phone: how AMD's Quality Score adds up from price action, the company, and signals, its rank, and the chart checks by group, trend, volume, tight range, and buying — Every line of the scoreWhat each part adds, and all 14 checks by group, on MEDP and every other stock.

The New alert form on a phone: watch one name, AMD, when its Quality Score is at least 20, sent by the bell on the site, a push notification, and email, with the Save alert button — Your own optional alertsPick what to watch, MEDP or your whole watchlist, and when: a Quality Score, a price, a filing. It comes by push, email, or the bell.

Prices refresh every 2.5 seconds during market hours.
Optional alerts by push, email, or the bell.
Add it to your Home Screen and it opens like an app.

The 14 checks

MEDP has 3 of 14 checks firing

One per group is shown here.

Trend1 of 5 shown

MA FAN 21 EMA W.EMA HH/HL 52W HI

Averages stacked in order, price near its high.

Volume1 of 3 shown

VOL VDU U/D VOL

Heavy volume on the run, quiet volume at rest.

Tight range1 of 3 shown

ATR SQZ SQUEEZE NR7

The daily range is tight against its own recent history.

Buying1 of 3 shown

OBV+CLOSE HI SPRING

Closes near the high, and buyers step in on dips.

The other 10 checks on MEDP, and all 14 on every stock.Get in free →

Also on the chart

Not scored

Shown for reference. None of these counts toward the Quality Score: in our tests on 20 years of daily prices, none of them improved it.

RSI 1446.3
Above 30, below 50.
MACD (12, 26, 9)Below signal
Crossed below its signal line 1 session ago.
50-day average$600.14
The price is 0.1% below it.
200-day average$523.81
The price is 14.4% above it. The 50-day is above the 200-day, since Aug 7.
ADX 1424.6
Under 25, with +DI below -DI.
Support$577.64
Swing low from Sep 10, 3.6% below the price.
Resistance$608.18
Swing high from Aug 11, 1.5% above the price.
Bollinger Bands (20, 2)Inside
The bands run from $579.02 to $637.95.
Volume1.3x
Against its 20-day average, for the time of day.

Its industry

How MEDP ranks in Biotech

MEDP is #37 of 300 by Quality Score. The top three are shown with their scores, and more by name.

1KNSAKiniksa Pharmaceuticals International7/1418
2EXELExelixis7/1417
3AMRXAmneal Pharmaceuticals6/1417
MAZEMaze TherapeuticsOpen for its score
MDGLMadrigal PharmaceuticalsOpen for its score
MIRMMirum PharmaceuticalsOpen for its score
MLYSMineralys TherapeuticsOpen for its score
37MEDPMedpace Holdings3/149

When does MEDP report earnings, and what happens after?

Reports Wed Oct 21, after the close (in 19 days). The company has set the date.

+9.1%-15.9%-22.6%+14.7%

Oct 22Feb 9Apr 22Jul 22

Reported	When	Gap	Reaction	5 sessions
Jul 22, 2026After close	After close	+22.5%	+14.7%	+10.8%
Apr 22, 2026After close	After close	-26.2%	-22.6%	-18.7%
Feb 9, 2026After close	After close	-7.8%	-15.9%	-19.3%
Oct 22, 2025After close	After close	+13.3%	+9.1%	+6.9%

The gap is the next open against the close before the report; the reaction is where that session closed. MEDP closed higher after 2 of its last 4. Past behavior, not a forecast.

Report dates and past reactions come from sessions that have already closed, so none of these figures move.

Filings

Who is trading MEDP

MEDP insider trades

7 insiders sold $177M across 27 filings in the last 6 months. No open-⁠market buys on record. The newest:

SellAugust J. Troendle$17.3MPresident & CEOat $621.33 on Sep 24, filed Sep 25

SellAugust J. TroendlePresident & CEO$17.3Mat $621.33 on Sep 24, filed Sep 25

All 27 insider filings on MEDP from the last six months, for Pro members.Get in free →

An insider has two business days to file a Form 4, so the trade is already days old when it becomes public. Shown as filed, with no delay.

MEDP trades by Congress and the White House

One trade disclosed in the last six months. The newest:

BuyDavid Taylor$1K to $15KHousetraded May 15, disclosed May 28(13 days later)

BuyDavid TaylorHouse$1K to $15Ktraded May 15, disclosed May 28(13 days later)

Congress gets 45 days to report a trade, so the two dates are weeks apart. Shown as filed, with no delay.

See what Congress is buying across the market

The company

About Medpace Holdings

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

6,500 employeesCincinnati, OHmedpace.com

Pro

Every line of the score, on every stock.

Real-time prices, no delay
Every line of MEDP's score, with the points and the reason
All 14 checks on MEDP and on all 3,243 stocks
Every stock ranked, with the chart
Every filing, and optional alerts on MEDP

BreakawayMay 28David Taylor bought MEDP$1K to $15K, disclosed May 28

What a filing on MEDP would have sent. Alerts are optional.

See all 14 checks on MEDPFree for 24 hours. No account needed. Then keep going with a free account.

Questions

Straight Answers.

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, trial included, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.

Where does the data come from?

Daily bars, quotes, reference data, headlines, and short interest come from Massive, formerly Polygon, a licensed market data vendor. The age of the quotes is shown at the top of every page. Insider trades, notable holders and profits come straight from the SEC. That means Form 4 filings, 13F filings and XBRL financial data on EDGAR. Government filings come from the public STOCK Act and Office of Government Ethics disclosures. The market-wide headlines on the market line also come from the public headline feeds CNBC, MarketWatch and Yahoo Finance publish, shown as the headline, the source and a link to the article. Splits, dividends, and the financial statements on each ticker page come from the vendor's reference data. The 8-K filings on EDGAR are read for the items that move a price. Five years of history is loaded for every stock. So the 200-day and 52-week checks rest on real history. Options flow is not part of the product.

Do I need an account?

Not for the first 24 hours. Tap any green button and you're in, with no email and no password. To keep going, create a free account with Google, Apple, or your email. There is no password to make up.

Is this investment advice?

No. It is a screening tool that scores stocks on the chart, the company's own results, and the news and filings. It does not know your situation and it is not a recommendation to buy or sell anything. Please do your own research.

The price, the score, the chart checks and readings, and the industry rank on this page are delayed at least 15 minutes. Filings are shown as filed, because a disclosure is already days or weeks old when it becomes public. Earnings dates and past reactions are settled sessions.